echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Clin Gastroenterology H: Delays in the treatment of Helicobacterrobacteria re-infection increase the risk of bleeding in the upper digestive tract

    Clin Gastroenterology H: Delays in the treatment of Helicobacterrobacteria re-infection increase the risk of bleeding in the upper digestive tract

    • Last Update: 2021-01-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    H.pylori infection is an independent risk factor for peptic ulcers.
    studies have shown that 43-56% of patients with peptic ulcer bleeding (PUB) have Helicobacter pyrethrobacteria infection.
    a recent study in Sweden showed that delaying the eradication of Helicobacterrobacteria increases the risk of ulcers and results in complications in a time-dependent manner.
    study aims to explore the effects of the failure of the initial eradication of Helicobacter pyridobacteria treatment on the risk of subsequent upper digestive bleeding (UGIB) at different times.
    researchers conducted a retrospective cohort study of 70,518 patients with Helicobacter pyridosis infection who received triple therapy based on clarithromycin from January 2003 to December 2012.
    8,330 patients, or 11.8 percent, needed retreated after the initial treatment failed.
    patients were classified according to the initial and final time (3 months or less, 3-12 months, and more than 12 months) to eradicate Helicobacter pyridosis.
    the main observational outcome was the difference in UBIBs between patients who needed retreated and those who did not.
    compared to the control group, patients who still needed retreated had a higher risk of UBEB (HR 1.50, 95% CI 1.34-1.69) even after the last eradication treatment.
    from initial eradication treatment to eventual eradication treatment, the longer the risk of UGIB increases: a risk ratio of less than 3 months is 1.16; .35;95%CI, 1.07-1.69, with a risk ratio of 1.68 for more than 12 months; 95%CI, 1.46-1.94 (P s .038).
    who initially failed to eradicate Helicobacterium were at increased risk of developing UGIB compared to patients who initially responded to the study.
    the risk increases as the time for retreation increases.
    should consider retreated as early as 3 months to minimize the risk of subsequent UBIBs.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.